As some of us keep making comparisons with Amarin;

-total revenue projected for 2019 from Vascepa is only $350Mil US.

-applying 1X potential annual sales takes it to $350 Mil US.

-it has a MC of approx $6 Bil US  ...... 17X projected 2019 sales.

-shares out 330 Mil

-it is prescribed for decreasing the amount of triglycerides made by the body and lowers MACE.

-I believe Amarin only manufactures one drug, Vascepa.

Koo